OCULAR THERAPEUTIX, INC (OCUL) Return on equity 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-40.6%FY2025 · since FY2016: -86.0% → -40.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -40.6% | +20.7 pp |
| FY2024 | -61.4% | +27.2 pp |
| FY2023 | -88.6% | +112.2 pp |
| FY2022 | -200.8% | -193.3 pp |
| FY2021 | -7.4% | +197.1 pp |
| FY2020 | -204.5% | — |
| FY2018 | -167.2% | +75.2 pp |
| FY2017 | -242.4% | -156.5 pp |
| FY2016 | -86.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice